Literature DB >> 30761212

An Update on the Pharmacological Treatment of Nonalcoholic Fatty Liver Disease: Beyond Lifestyle Modifications.

Naim Alkhouri1,2, Andrea Scott1.   

Abstract

Entities:  

Year:  2018        PMID： 30761212      PMCID： PMC6370316          DOI： 10.1002/cld.708

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


× No keyword cloud information.
  9 in total

1.  Hepatocyte Deletion of Triglyceride-Synthesis Enzyme Acyl CoA: Diacylglycerol Acyltransferase 2 Reduces Steatosis Without Increasing Inflammation or Fibrosis in Mice.

Authors:  Nina L Gluchowski; Katlyn R Gabriel; Chandramohan Chitraju; Roderick T Bronson; Niklas Mejhert; Sebastian Boland; Kun Wang; Zon Weng Lai; Robert V Farese; Tobias C Walther
Journal:  Hepatology       Date:  2019-06-26       Impact factor: 17.425

2.  PPDPF alleviates hepatic steatosis through inhibition of mTOR signaling.

Authors:  Ning Ma; Yi-Kang Wang; Sheng Xu; Qian-Zhi Ni; Qian-Wen Zheng; Bing Zhu; Hui-Jun Cao; Hao Jiang; Feng-Kun Zhang; Yan-Mei Yuan; Er-Bin Zhang; Tian-Wei Chen; Ji Xia; Xu-Fen Ding; Zhen-Hua Chen; Xiu-Ping Zhang; Kang Wang; Shu-Qun Cheng; Lin Qiu; Zhi-Gang Li; Yong-Chun Yu; Xiao-Fan Wang; Bin Zhou; Jing-Jing Li; Dong Xie
Journal:  Nat Commun       Date:  2021-05-24       Impact factor: 14.919

Review 3.  Potential Therapeutic Application of Estrogen in Gender Disparity of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis.

Authors:  Chanbin Lee; Jieun Kim; Youngmi Jung
Journal:  Cells       Date:  2019-10-15       Impact factor: 6.600

4.  Saroglitazar in patients with non-alcoholic fatty liver disease and diabetic dyslipidemia: a prospective, observational, real world study.

Authors:  Omesh Goyal; Sahil Nohria; Prerna Goyal; Jaskirat Kaur; Sarit Sharma; Ajit Sood; Rajoo Singh Chhina
Journal:  Sci Rep       Date:  2020-12-03       Impact factor: 4.379

5.  Metformin treatment reverses high fat diet- induced non-alcoholic fatty liver diseases and dyslipidemia by stimulating multiple antioxidant and anti-inflammatory pathways.

Authors:  Tahmina Yasmin; Md Mizanur Rahman; Ferdous Khan; Fariha Kabir; Kamrun Nahar; Shoumen Lasker; Md Didarul Islam; Mohammad Maqsud Hossain; Raquibul Hasan; Sohel Rana; Md Ashraful Alam
Journal:  Biochem Biophys Rep       Date:  2021-11-17

6.  Circulating Neutrophils of Nonalcoholic Steatohepatitis Patients Show an Activated Phenotype and Suppress T Lymphocytes Activity.

Authors:  Laura Antonucci; Cristiana Porcu; Eleonora Timperi; Silvano Junior Santini; Gino Iannucci; Clara Balsano
Journal:  J Immunol Res       Date:  2020-06-30       Impact factor: 4.818

7.  L-Ornithine L-Aspartate (LOLA) as a Novel Approach for Therapy of Non-alcoholic Fatty Liver Disease.

Authors:  Ali Canbay; Jan-Peter Sowa
Journal:  Drugs       Date:  2019-02       Impact factor: 9.546

Review 8.  Chinese Medicinal Herbs Targeting the Gut-Liver Axis and Adipose Tissue-Liver Axis for Non-Alcoholic Fatty Liver Disease Treatments: The Ancient Wisdom and Modern Science.

Authors:  Shuwei Zhang; Yui-Tung Wong; Ka-Yu Tang; Hiu-Yee Kwan; Tao Su
Journal:  Front Endocrinol (Lausanne)       Date:  2020-09-30       Impact factor: 5.555

9.  Effectiveness and safety of Shugan Jianpi (SGJP) formula in the treatment of nonalcoholic steatohepatitis (NASH): A protocol for systematic review and meta-analysis of randomized controlled trials.

Authors:  Mingtai Chen; Yanghui Gu; Furong Huang; Guofu Zhong; Ling Men; Qiang Liu; Jienan Luan; Guangdong Tong
Journal:  Medicine (Baltimore)       Date:  2021-12-23       Impact factor: 1.817
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.